Literature DB >> 20101143

Tgf-beta signaling pathway in lung adenocarcinoma invasion.

Rebecca L Toonkel1, Alain C Borczuk, Charles A Powell.   

Abstract

The histologic distinction between bronchioloalveolar carcinoma and other adenocarcinomas is tissue invasion. The clinical importance of lung adenocarcinoma invasion is supported by several recent studies indicating that the risk of death in nonmucinous bronchioloalveolar carcinoma is significantly lower than that of pure invasive tumors and in tumors with greater than 0.5 cm of fibrosis or linear invasion. Using microarray gene expression profiling of human tumors, dysregulation of transforming growth factor-beta signaling was identified as an important mediator of tumor invasion. Subsequent studies showed that the CC chemokine regulated on activation, normal T cell expressed, and presumably secreted was up-regulated in invasive tumors and was required for invasion in cells with repressed levels of the transforming growth factor-beta type II receptor. Taken together, these studies illustrate how information gained from global expression profiling of tumors can be used to identify key pathways and genes mediating tumor growth, invasion, and metastasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101143      PMCID: PMC2992959          DOI: 10.1097/JTO.0b013e3181c8cc0c

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  81 in total

1.  Modified scar grade: a prognostic indicator in small peripheral lung adenocarcinoma.

Authors:  Akiko M Maeshima; Toshiro Niki; Arafumi Maeshima; Tesshi Yamada; Haruhiko Kondo; Yoshihiro Matsuno
Journal:  Cancer       Date:  2002-12-15       Impact factor: 6.860

Review 2.  The two faces of transforming growth factor beta in carcinogenesis.

Authors:  Anita B Roberts; Lalage M Wakefield
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-14       Impact factor: 11.205

3.  Stage I pure bronchioloalveolar carcinoma: recurrences, survival and comparison with adenocarcinoma of the lung.

Authors:  Ottavio Rena; Esther Papalia; Enrico Ruffini; Caterina Casadio; Pier Luigi Filosso; Alberto Oliaro; Giuliano Maggi
Journal:  Eur J Cardiothorac Surg       Date:  2003-03       Impact factor: 4.191

4.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited.

Authors:  Isaiah J Fidler
Journal:  Nat Rev Cancer       Date:  2003-06       Impact factor: 60.716

5.  Mutational analysis of the transforming growth factor beta receptor type I gene in primary non-small cell lung cancer.

Authors:  Hong-Tao Zhang; Qing-Yan Fei; Feng Chen; Qing-Yuan Qi; Wei Zou; Jiu-Cun Wang; Rong-Mei Zhang; Shi-Heng Tao; Xiao-Feng Chen; Ze-Wei Luo
Journal:  Lung Cancer       Date:  2003-06       Impact factor: 5.705

6.  Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects.

Authors:  Yu-An Yang; Oksana Dukhanina; Binwu Tang; Mizuko Mamura; John J Letterio; Jennifer MacGregor; Sejal C Patel; Shahram Khozin; Zi-Yao Liu; Jeffrey Green; Miriam R Anver; Glenn Merlino; Lalage M Wakefield
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

7.  Gene-expression profiles predict survival of patients with lung adenocarcinoma.

Authors:  David G Beer; Sharon L R Kardia; Chiang-Ching Huang; Thomas J Giordano; Albert M Levin; David E Misek; Lin Lin; Guoan Chen; Tarek G Gharib; Dafydd G Thomas; Michelle L Lizyness; Rork Kuick; Satoru Hayasaka; Jeremy M G Taylor; Mark D Iannettoni; Mark B Orringer; Samir Hanash
Journal:  Nat Med       Date:  2002-07-15       Impact factor: 53.440

8.  Lung adenocarcinoma with mixed bronchioloalveolar and invasive components: clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization.

Authors:  Hiroshi Terasaki; Toshiro Niki; Yoshihiro Matsuno; Tesshi Yamada; Arafumi Maeshima; Hisao Asamura; Naofumi Hayabuchi; Setsuo Hirohashi
Journal:  Am J Surg Pathol       Date:  2003-07       Impact factor: 6.394

9.  Effects of transforming growth factor beta (TGF-beta) receptor on lung carcinogenesis.

Authors:  Chaehwa Park; Won-Seog Kim; Yunseon Choi; Haesung Kim; Keunchil Park
Journal:  Lung Cancer       Date:  2002-11       Impact factor: 5.705

10.  Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis.

Authors:  Peter M Siegel; Weiping Shu; Robert D Cardiff; William J Muller; Joan Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 12.779

View more
  28 in total

1.  Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinoma.

Authors:  Sweta Rani; Kathy Gately; John Crown; Ken O'Byrne; Lorraine O'Driscoll
Journal:  Cancer Biol Ther       Date:  2013-09-04       Impact factor: 4.742

Review 2.  Update in lung cancer and mesothelioma 2012.

Authors:  Charles A Powell; Balazs Halmos; Serge P Nana-Sinkam
Journal:  Am J Respir Crit Care Med       Date:  2013-07-15       Impact factor: 21.405

3.  Update in lung cancer and oncological disorders 2010.

Authors:  Balazs Halmos; Charles A Powell
Journal:  Am J Respir Crit Care Med       Date:  2011-08-01       Impact factor: 21.405

4.  Simvastatin downregulates expression of TGF-βRII and inhibits proliferation of A549 cells via ERK.

Authors:  Li Shang; Shu-Shan Jia; Hai-Ming Jiang; Hua Wang; Wen-Hua Xu; Chang-Jun Lv
Journal:  Tumour Biol       Date:  2015-01-29

5.  Dual roles of TGF-β signaling in the regulation of dental epithelial cell proliferation.

Authors:  Hao Zhang; Yunyan Zhan; Yue Zhang; Guohua Yuan; Guobin Yang
Journal:  J Mol Histol       Date:  2020-11-18       Impact factor: 2.611

6.  Multi-walled carbon nanotube-induced gene expression in the mouse lung: association with lung pathology.

Authors:  M Pacurari; Y Qian; D W Porter; M Wolfarth; Y Wan; D Luo; M Ding; V Castranova; N L Guo
Journal:  Toxicol Appl Pharmacol       Date:  2011-05-23       Impact factor: 4.219

Review 7.  Lung cancer in never smokers.

Authors:  Ping Yang
Journal:  Semin Respir Crit Care Med       Date:  2011-04-15       Impact factor: 3.119

8.  Comparative profiling of miRNA expression of lung adenocarcinoma cells in two-dimensional and three-dimensional cultures.

Authors:  Cui Li; Hong T Nguyen; Yan Zhuang; Zhen Lin; Erik K Flemington; Ying Zhuo; Stephen P Kantrow; Gilbert F Morris; Deborah E Sullivan; Bin Shan
Journal:  Gene       Date:  2012-10-02       Impact factor: 3.688

9.  Vascular endothelial growth factor induces CXCL1 chemokine release via JNK and PI-3K-dependent pathways in human lung carcinoma epithelial cells.

Authors:  Huey-Ming Lo; Jiunn-Min Shieh; Chih-Li Chen; Chih-Jen Tsou; Wen-Bin Wu
Journal:  Int J Mol Sci       Date:  2013-05-10       Impact factor: 5.923

10.  Bronchioloalveolar invasion in non-small cell lung cancer is associated with expression of transforming growth factor-β1.

Authors:  Kazuhiro Imai; Yoshihiro Minamiya; Akiteru Goto; Hiroshi Nanjo; Hajime Saito; Satoru Motoyama; Yusuke Sato; Satoshi Kudo; Shinogu Takashima; Yasushi Kawaharada; Nobuyasu Kurihara; Kimito Orino; Jun-ichi Ogawa
Journal:  World J Surg Oncol       Date:  2013-05-25       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.